537 related articles for article (PubMed ID: 28257476)
1. Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome.
de Montalembert M; Ribeil JA; Brousse V; Guerci-Bresler A; Stamatoullas A; Vannier JP; Dumesnil C; Lahary A; Touati M; Bouabdallah K; Cavazzana M; Chauzit E; Baptiste A; Lefebvre T; Puy H; Elie C; Karim Z; Ernst O; Rose C
PLoS One; 2017; 12(3):e0172147. PubMed ID: 28257476
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major.
Aubart M; Ou P; Elie C; Canniffe C; Kutty S; Delos V; Graffigne C; de Montalembert M; Brousse V
J Pediatr Hematol Oncol; 2016 Oct; 38(7):497-502. PubMed ID: 27548334
[TBL] [Abstract][Full Text] [Related]
3. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
[TBL] [Abstract][Full Text] [Related]
4. Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload.
Nolte F; Höchsmann B; Giagounidis A; Lübbert M; Platzbecker U; Haase D; Lück A; Gattermann N; Taupitz M; Baier M; Leismann O; Junkes A; Schumann C; Hofmann WK; Schrezenmeier H
Ann Hematol; 2013 Jan; 92(2):191-8. PubMed ID: 23073603
[TBL] [Abstract][Full Text] [Related]
5. Cardiac iron overload in sickle-cell disease.
Meloni A; Puliyel M; Pepe A; Berdoukas V; Coates TD; Wood JC
Am J Hematol; 2014 Jul; 89(7):678-83. PubMed ID: 24664847
[TBL] [Abstract][Full Text] [Related]
6. Increased sympathovagal imbalance evaluated by heart rate variability is associated with decreased T2* MRI and left ventricular function in transfusion-dependent thalassemia patients.
Pattanakuhar S; Phrommintikul A; Tantiworawit A; Konginn S; Srichairattanakool S; Chattipakorn SC; Chattipakorn N
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29330222
[TBL] [Abstract][Full Text] [Related]
7. Heart Rate Variability for Early Detection of Cardiac Iron Deposition in Patients with Transfusion-Dependent Thalassemia.
Silvilairat S; Charoenkwan P; Saekho S; Tantiworawit A; Phrommintikul A; Srichairatanakool S; Chattipakorn N
PLoS One; 2016; 11(10):e0164300. PubMed ID: 27737009
[TBL] [Abstract][Full Text] [Related]
8. Myocardial and liver iron overload, assessed using T2* magnetic resonance imaging with an excel spreadsheet for post processing in Tunisian thalassemia major patients.
Ouederni M; Ben Khaled M; Mellouli F; Ben Fraj E; Dhouib N; Yakoub IB; Abbes S; Mnif N; Bejaoui M
Ann Hematol; 2017 Jan; 96(1):133-139. PubMed ID: 27730342
[TBL] [Abstract][Full Text] [Related]
9. Ferritin trends do not predict changes in total body iron in patients with transfusional iron overload.
Puliyel M; Sposto R; Berdoukas VA; Hofstra TC; Nord A; Carson S; Wood J; Coates TD
Am J Hematol; 2014 Apr; 89(4):391-4. PubMed ID: 24347294
[TBL] [Abstract][Full Text] [Related]
10. Observational Monitoring of Patients with Aplastic Anemia and Low/Intermediate-1 Risk of Myelodysplastic Syndromes Complicated with Iron Overload.
Du Y; Long Z; Chen M; Han B; Hou B; Feng F
Acta Haematol; 2017; 138(2):119-128. PubMed ID: 28866669
[TBL] [Abstract][Full Text] [Related]
11. Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study).
Ho PJ; Tay L; Teo J; Marlton P; Grigg A; St Pierre T; Brown G; Badcock CA; Traficante R; Gervasio OL; Bowden DK
Eur J Haematol; 2017 Feb; 98(2):97-105. PubMed ID: 27537786
[TBL] [Abstract][Full Text] [Related]
12. Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell disease.
Badawy SM; Liem RI; Rigsby CK; Labotka RJ; DeFreitas RA; Thompson AA
Br J Haematol; 2016 Nov; 175(4):705-713. PubMed ID: 27507431
[TBL] [Abstract][Full Text] [Related]
13. Clinical consequences of iron overload in patients with myelodysplastic syndromes: the case for iron chelation therapy.
Shammo JM; Komrokji RS
Expert Rev Hematol; 2018 Jul; 11(7):577-586. PubMed ID: 29902097
[TBL] [Abstract][Full Text] [Related]
14. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.
Inati A; Musallam KM; Wood JC; Sheikh-Taha M; Daou L; Taher AT
Eur J Haematol; 2009 Dec; 83(6):565-71. PubMed ID: 19737308
[TBL] [Abstract][Full Text] [Related]
15. Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease.
Wood JC; Tyszka JM; Carson S; Nelson MD; Coates TD
Blood; 2004 Mar; 103(5):1934-6. PubMed ID: 14630822
[TBL] [Abstract][Full Text] [Related]
16. Assessment of liver and cardiac iron overload using MRI in patients with chronic anemias in Latin American countries: results from ASIMILA study.
Cancado R; Watman NP; Lobo C; Chona Z; Manzur F; Traina F; Park M; Drelichman G; Zarate JP; Marfil L
Hematology; 2018 Oct; 23(9):676-682. PubMed ID: 29663858
[TBL] [Abstract][Full Text] [Related]
17. [Study of iron overload assessment by T2* magnetic resonance imaging in patients with myelodysplastic syndromes].
Song LL; Lu HY; Xiao C; Wu LY; Wu D; Su JY; Zhou LY; Chang CK
Zhonghua Xue Ye Xue Za Zhi; 2019 Mar; 40(3):222-226. PubMed ID: 30929390
[No Abstract] [Full Text] [Related]
18. Role of non-invasive assessment in prediction of preclinical cardiac affection in multi-transfused thalassaemia major patients.
Said Othman KM; Elshazly SA; Heiba NM
Hematology; 2014 Oct; 19(7):380-7. PubMed ID: 24225039
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of anemia and transfusion iron overload in myelodysplastic syndromes.
Cazzola M; Della Porta MG; Malcovati L
Hematology Am Soc Hematol Educ Program; 2008; ():166-75. PubMed ID: 19074076
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of plasma non-transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patients.
Porter JB; Walter PB; Neumayr LD; Evans P; Bansal S; Garbowski M; Weyhmiller MG; Harmatz PR; Wood JC; Miller JL; Byrnes C; Weiss G; Seifert M; Grosse R; Grabowski D; Schmidt A; Fischer R; Nielsen P; Niemeyer C; Vichinsky E
Br J Haematol; 2014 Dec; 167(5):692-6. PubMed ID: 25209728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]